Ingevity Corp reported Q2 2026 revenue of $314.1M and net income of $35.3M, recovering from prior-year losses. Despite a 5% sales decline due to divestitures, Performance Materials and APT segments sh
Ingevity Corp reported strong Q2 2026 financial results with $314.1 million in sales, raising full-year guidance. The company plans to reduce leverage and focus on carbon technologies following the Ro
Ingevity Corporation released its Q2 2026 earnings call presentation, reporting an EPS of $1.74 that exceeded estimates by $0.41. Revenue totaled $314.10 million, beating forecasts despite a 13.97% ye
Ingevity Corporation reported Q2 adjusted earnings per share of $1.74, significantly beating FactSet estimates of $1.33. This positive performance highlights strong quarterly results for the specialty
Ingevity Corp released a brief snapshot of its second-quarter earnings, though specific financial details remain unavailable due to limited reporting content.
Ingevity Corp beat Q2 2026 earnings expectations with an EPS of $1.74, driven by high demand for activated carbon and specialty polymers. Management raised full-year adjusted EPS guidance to $5.00-$5.
Ingevity Corp announces second-quarter earnings with analysts expecting improved sequential performance despite a year-over-year decline. Investors will watch if the specialty chemicals maker can reve
Ingevity Corp filed a Form 4 on July 29 as reported by Investing.com. Details regarding the filing contents are not disclosed, only the stock symbol NGVT is confirmed.
Ingevity Corp submitted a Form 4 filing disclosing insider transactions on July 8, 2026, according to Investing.com.
Ingevity Corp. announced it will release Q2 2026 financial results on July 23, 2026, before market open, with a live webcast and conference call.
Ingevity Corporation will release its second quarter 2026 financial results after market close on July 29, followed by a live webcast discussion on July 30.
ChemBrief